Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)

GOAL: To determine efficacy and safety of treatment with Rituximab and Etanercept plus Methotrexate in patients with active Rheumatoid Arthritis (RA), who had an inadequate response to nonbiologic DMARDS therapies and to explore the pharmacogenetics and pharmacodynamics of Rituximab and Etanercept i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gashi, Afrim A., Rexhepi, Sylejman, Berisha, Idriz, Kryeziu, Avni, Ismaili, Jehona, Krasniqi, Gezim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVICENA, d.o.o., Sarajevo 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272488/
https://www.ncbi.nlm.nih.gov/pubmed/24783914
http://dx.doi.org/10.5455/medarh.2014.68.51-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272488/
https://www.ncbi.nlm.nih.gov/pubmed/24783914
http://dx.doi.org/10.5455/medarh.2014.68.51-53

Ejemplares similares